Aneta Wlodarczyk (Aneta Włodarczyk)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Tyrosine Kinase

Neural Stem Cells

Epidermal Growth Factor Receptor

Top Venues

International journal of molecular sciences

Journal of oncology

Journal of cellular and molecular medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Cezary Tręda, Aneta Wlodarczyk, Piotr Rieske
The hope, hype and obstacles surrounding cell therapy. Journal of cellular and molecular medicine 28 (10) (2024)
Cezary Tręda, Aneta Wlodarczyk, Piotr Rieske
The hope, hype and obstacles surrounding cell therapy. Journal of cellular and molecular medicine 28 (10) (2024)
Cezary Tręda, Aneta Wlodarczyk, Marcin Pacholczyk, Adrianna Rutkowska, Ewelina Stoczyńska-Fidelus, Amelia Kierasińska, Piotr Rieske
Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy. International journal of molecular sciences 24 (5) (2023)
Cezary Tręda, Aneta Wlodarczyk, Marcin Pacholczyk, Adrianna Rutkowska, Ewelina Stoczyńska-Fidelus, Amelia Kierasińska, Piotr Rieske
Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy. International journal of molecular sciences 24 (5) (2023)
Cezary Tręda, Aneta Wlodarczyk, Marcin Pacholczyk, Adrianna Rutkowska, Ewelina Stoczyńska-Fidelus, Amelia Kierasińska, Piotr Rieske
Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy. International journal of molecular sciences 24 (5) (2023)
Cezary Tręda, Aneta Wlodarczyk, Marcin Pacholczyk, Adrianna Rutkowska, Ewelina Stoczyńska-Fidelus, Amelia Kierasińska, Piotr Rieske
Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy. International journal of molecular sciences 24 (5) (2023)
Aneta Wlodarczyk, Cezary Tręda, Adrianna Rutkowska, Dagmara Grot, Weronika Dobrewa, Amelia Kierasińska, Marta Węgierska, Tomasz Wasiak, Tadeusz Strózik, Piotr Rieske, Ewelina Stoczyńska-Fidelus
Phenotypical Flexibility of the EGFRvIII-Positive Glioblastoma Cell Line and the Multidirectional Influence of TGFβ and EGF on These Cells-EGFRvIII Appears as a Weak Oncogene. International journal of molecular sciences 23 (20) (2022)
Aneta Wlodarczyk, Dagmara Grot, Ewelina Stoczyńska-Fidelus, Piotr Rieske
Gaps and Doubts in Search to Recognize Glioblastoma Cellular Origin and Tumor Initiating Cells. Journal of oncology 2020 (2020)
Adrianna Rutkowska, Ewelina Stoczyńska-Fidelus, Karolina Janik, Aneta Wlodarczyk, Piotr Rieske
EGFRvIII: An Oncogene with Ambiguous Role. Journal of oncology 2019 (2019)